Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States

Theodore J. Cicero, Hilary Surratt, James A. Inciardi, Alvaro Munoz

Research output: Contribution to journalArticle

Abstract

Purpose: The goal of these studies was to determine the relationship between prescribed use of opioid analgesics and their non-medically related use (abuse) at a regional level across the country. Methods: To gather information about prescription drug abuse, we asked 233 drug abuse treatment specialists to provide us Quarterly reports on the number of cases of prescription opioid analgesic abusers who used opioid analgesics to get high in the past 30 days. Results and conclusions: We found that there was a very strong correlation between therapeutic exposure to opioid analgesics, as measured by prescriptions filled, and their abuse. There were, however, geographical loci that represented outliers in which abuse was disproportionately high relative to therapeutic use (>95th percentile), most of which were in very small urban, suburban, and rural areas. The rank order of abuse shows that buprenorphine products, extended release (ER) oxycodone and methadone are the most intensely abused prescription opioid analgesics, with hydrocodone the least abused, when the data are corrected for degree of exposure, i.e., cases/ 1000 persons filling a prescription. If, on the other hand, one uses the number of cases/100 000 population, hydrocodone ranked as high as ER oxycodone and all other drugs grouped together at very low levels of abuse. Since the latter conclusion ignores therapeutic exposure, we conclude that the rate of abuse of highly efficacious opioid analgesics is best expressed as cases of abuse/1000 persons filling a prescription, which yields the best possible estimate of the risk-benefit ratio of these drugs.

Original languageEnglish (US)
Pages (from-to)827-840
Number of pages14
JournalPharmacoepidemiology and Drug Safety
Volume16
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Therapeutic Uses
Opioid Analgesics
Prescriptions
Hydrocodone
Oxycodone
Prescription Drug Misuse
Buprenorphine
Methadone
Pharmaceutical Preparations
Substance-Related Disorders
Therapeutics
Odds Ratio
Population

Keywords

  • Drug abuse
  • Drug diversion
  • Opioid analgesics
  • Post-marketing surveillance
  • Risk management
  • Risk-benefit
  • Therapeutic use and abuse of opioid analgesics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. / Cicero, Theodore J.; Surratt, Hilary; Inciardi, James A.; Munoz, Alvaro.

In: Pharmacoepidemiology and Drug Safety, Vol. 16, No. 8, 08.2007, p. 827-840.

Research output: Contribution to journalArticle

@article{3cdf0443adcd42d4818ff7860289723a,
title = "Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States",
abstract = "Purpose: The goal of these studies was to determine the relationship between prescribed use of opioid analgesics and their non-medically related use (abuse) at a regional level across the country. Methods: To gather information about prescription drug abuse, we asked 233 drug abuse treatment specialists to provide us Quarterly reports on the number of cases of prescription opioid analgesic abusers who used opioid analgesics to get high in the past 30 days. Results and conclusions: We found that there was a very strong correlation between therapeutic exposure to opioid analgesics, as measured by prescriptions filled, and their abuse. There were, however, geographical loci that represented outliers in which abuse was disproportionately high relative to therapeutic use (>95th percentile), most of which were in very small urban, suburban, and rural areas. The rank order of abuse shows that buprenorphine products, extended release (ER) oxycodone and methadone are the most intensely abused prescription opioid analgesics, with hydrocodone the least abused, when the data are corrected for degree of exposure, i.e., cases/ 1000 persons filling a prescription. If, on the other hand, one uses the number of cases/100 000 population, hydrocodone ranked as high as ER oxycodone and all other drugs grouped together at very low levels of abuse. Since the latter conclusion ignores therapeutic exposure, we conclude that the rate of abuse of highly efficacious opioid analgesics is best expressed as cases of abuse/1000 persons filling a prescription, which yields the best possible estimate of the risk-benefit ratio of these drugs.",
keywords = "Drug abuse, Drug diversion, Opioid analgesics, Post-marketing surveillance, Risk management, Risk-benefit, Therapeutic use and abuse of opioid analgesics",
author = "Cicero, {Theodore J.} and Hilary Surratt and Inciardi, {James A.} and Alvaro Munoz",
year = "2007",
month = "8",
doi = "10.1002/pds.1452",
language = "English (US)",
volume = "16",
pages = "827--840",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States

AU - Cicero, Theodore J.

AU - Surratt, Hilary

AU - Inciardi, James A.

AU - Munoz, Alvaro

PY - 2007/8

Y1 - 2007/8

N2 - Purpose: The goal of these studies was to determine the relationship between prescribed use of opioid analgesics and their non-medically related use (abuse) at a regional level across the country. Methods: To gather information about prescription drug abuse, we asked 233 drug abuse treatment specialists to provide us Quarterly reports on the number of cases of prescription opioid analgesic abusers who used opioid analgesics to get high in the past 30 days. Results and conclusions: We found that there was a very strong correlation between therapeutic exposure to opioid analgesics, as measured by prescriptions filled, and their abuse. There were, however, geographical loci that represented outliers in which abuse was disproportionately high relative to therapeutic use (>95th percentile), most of which were in very small urban, suburban, and rural areas. The rank order of abuse shows that buprenorphine products, extended release (ER) oxycodone and methadone are the most intensely abused prescription opioid analgesics, with hydrocodone the least abused, when the data are corrected for degree of exposure, i.e., cases/ 1000 persons filling a prescription. If, on the other hand, one uses the number of cases/100 000 population, hydrocodone ranked as high as ER oxycodone and all other drugs grouped together at very low levels of abuse. Since the latter conclusion ignores therapeutic exposure, we conclude that the rate of abuse of highly efficacious opioid analgesics is best expressed as cases of abuse/1000 persons filling a prescription, which yields the best possible estimate of the risk-benefit ratio of these drugs.

AB - Purpose: The goal of these studies was to determine the relationship between prescribed use of opioid analgesics and their non-medically related use (abuse) at a regional level across the country. Methods: To gather information about prescription drug abuse, we asked 233 drug abuse treatment specialists to provide us Quarterly reports on the number of cases of prescription opioid analgesic abusers who used opioid analgesics to get high in the past 30 days. Results and conclusions: We found that there was a very strong correlation between therapeutic exposure to opioid analgesics, as measured by prescriptions filled, and their abuse. There were, however, geographical loci that represented outliers in which abuse was disproportionately high relative to therapeutic use (>95th percentile), most of which were in very small urban, suburban, and rural areas. The rank order of abuse shows that buprenorphine products, extended release (ER) oxycodone and methadone are the most intensely abused prescription opioid analgesics, with hydrocodone the least abused, when the data are corrected for degree of exposure, i.e., cases/ 1000 persons filling a prescription. If, on the other hand, one uses the number of cases/100 000 population, hydrocodone ranked as high as ER oxycodone and all other drugs grouped together at very low levels of abuse. Since the latter conclusion ignores therapeutic exposure, we conclude that the rate of abuse of highly efficacious opioid analgesics is best expressed as cases of abuse/1000 persons filling a prescription, which yields the best possible estimate of the risk-benefit ratio of these drugs.

KW - Drug abuse

KW - Drug diversion

KW - Opioid analgesics

KW - Post-marketing surveillance

KW - Risk management

KW - Risk-benefit

KW - Therapeutic use and abuse of opioid analgesics

UR - http://www.scopus.com/inward/record.url?scp=34548283471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548283471&partnerID=8YFLogxK

U2 - 10.1002/pds.1452

DO - 10.1002/pds.1452

M3 - Article

VL - 16

SP - 827

EP - 840

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 8

ER -